You are here: Home :: Area NEM :: Life sciences :: Biochemistry

John M. Stewart, Lajos Gera, Eunice J. York, Daniel C. Chan, Eric J. Whalleya, Paul A. Bunn jr., Raymond J. Vavrek

Metabolism-Resistant Bradykinin Antagonists: Development and Applications

Bradykinin plays many roles in normal and pathological physiology, but rapid enzymatic degradation made elucidation of its functions extremely difficult. Development of effective degradation-resistant antagonists made it possible to delineate these roles and to open the way for development of new drugs to control pathology due to excess production of bradykinin. Presently available peptide bradykinin antagonists are extremely potent, are completely resistant to enzymatic degradation, and are orally available. Non-peptide bradykinin antagonists have also been discovered. Development of bradykinin antagonists as drugs for cancer, inflammation and trauma is anticipated.

Biological Chemistry, Walter de Gruyter

Print ISSN: 1431-6730
Volume: 382, 02/2001
Pages: 37 - 41

Show full article (external site)

Show all available items of this journal

 

Area NEM